AMO FORM 8-K, APRIL 21, 2004

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 21, 2004

 

 

ADVANCED MEDICAL OPTICS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   01-31257   33-0986820

(State or other jurisdiction

of incorporation)

   (Commission File Number)   (IRS Employer Identification No.)

 

1700 E. St. Andrew Place Santa Ana, CA   92705
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (714) 247-8200

 

(Former name or former address, if changed since last report)

 

Item 5. Other Events and Regulation FD Disclosure.

 

On April 21, 2004, Advanced Medical Optics, Inc. announced that it has entered into a definitive agreement to acquire from Pfizer Inc. Pfizer’s surgical ophthalmology business. A copy of the Press Release is filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by this reference.

 

Item 7. Financial Statements and Exhibits.

 

Exhibit 99.1    Press Release, dated April 21, 2004, issued by Advanced Medical Optics, Inc., announcing agreement to acquire Pfizer’s surgical ophthalmology business

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    

ADVANCED MEDICAL OPTICS, INC.

(Registrant)

     By:   

/s/ RICHARD A. MEIER

Date: April 22, 2004        

Richard A. Meier, Executive Vice

         

President of Operations and Finance and Chief Financial Officer

EXHIBIT INDEX

 

 

Exhibit
No.		     
99.1    Press release, dated April 21, 2004, issued by Advanced Medical Optics, Inc., announcing agreement to acquire Pfizer’s surgical ophthalmology business